Royalty Pharma (RPRXN) Q3 2023 Earnings Report

1 Followers

MX:RPRXN Upcoming Earnings

Royalty Pharma's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q3 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:RPRXN earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 16, 2027	2026 (Q4)	29.13-	27.27	―	―
Nov 04, 2026	2026 (Q3)	21.9722.47	21.82	2.98% (+0.65)
Aug 05, 2026	2026 (Q2)	23.6824.57	21.22	15.78% (+3.35)
May 06, 2026	2026 (Q1)	22.5824.11	13.93	73.03% (+10.17)
Feb 11, 2026	2025 (Q4)	23.9227.27	21.41	27.37% (+5.86)
Nov 05, 2025	2025 (Q3)	18.4921.82	17.06	27.92% (+4.76)
Aug 06, 2025	2025 (Q2)	19.2021.22	17.87	18.73% (+3.35)
May 08, 2025	2025 (Q1)	17.7313.93	18.19	-23.42% (-4.26)
Feb 11, 2025	2024 (Q4)	19.6221.41	21.37	0.17% (+0.04)
Nov 06, 2024	2024 (Q3)	17.2417.06	14.68	16.22% (+2.38)
Aug 08, 2024	2024 (Q2)	17.9517.87	15.72	13.73% (+2.16)
May 09, 2024	2024 (Q1)	18.3618.19	29.82	-38.99% (-11.62)
Feb 15, 2024	2023 (Q4)	18.7921.37	28.98	-26.25% (-7.61)
Nov 08, 2023	2023 (Q3)	14.3214.68	13.52	8.53% (+1.15)
Aug 08, 2023	2023 (Q2)	15.4415.72	15.08	4.19% (+0.63)
May 09, 2023	2023 (Q1)	23.7029.82	11.16	167.17% (+18.66)
Feb 15, 2023	2022 (Q4)	27.3828.98	14.88	94.75% (+14.10)
Nov 08, 2022	2022 (Q3)	13.1913.52	13.52	0.00% (+0.00)
Aug 04, 2022	2022 (Q2)	14.5315.08	13.52	11.55% (+1.56)
May 05, 2022	2022 (Q1)	13.6211.16	12.54	-10.98% (-1.38)
Feb 15, 2022	2021 (Q4)	14.4114.88	12.96	14.78% (+1.92)
Nov 10, 2021	2021 (Q3)	13.0213.52	8.91	51.77% (+4.61)
Aug 11, 2021	2021 (Q2)	13.0813.52	13.54	-0.14% (-0.02)
May 11, 2021	2021 (Q1)	―12.54	9.17	36.71% (+3.37)
Feb 17, 2021	2020 (Q4)	―12.96	72.2	-82.05% (-59.24)
Nov 10, 2020	2020 (Q3)	―8.91	20.79	-57.16% (-11.89)
Aug 12, 2020	2020 (Q2)	―13.54	7.72	75.42% (+5.82)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed